Auris Health

What Auris Health does

Auris Health, founded in 2007 and headquartered in Redwood City, California, is a medical robotics company that operates as a wholly-owned subsidiary of Johnson & Johnson MedTech following J&J's $3.4 billion acquisition in 2019. The company develops the MONARCH Platform, the first FDA-cleared flexible, robotically-assisted bronchoscopy system designed to provide physicians with access to and continuous visualization of patient airways to enable biopsy of suspicious lung nodules. The platform uses AI-powered navigation algorithms, an independently articulating telescoping scope and sheath, and an integrated camera for real-time visualization, enabling reach into all eighteen lung segments and approximately 48% of nodules located in the peripheral third of the lung that are inaccessible to conventional bronchoscopy. The enhanced MONARCH QUEST variant launched in 2025 adds more powerful AI navigation and integrates with GE HealthCare OEC 3D and Siemens Healthineers Cios Spin intraoperative imaging systems for 3D tool-in-lesion confirmation.

The company's revenue model combines one-time capital equipment sales of the MONARCH system to hospitals and healthcare systems with recurring per-procedure revenue from single-use consumables and biopsy accessories. Products are distributed exclusively through J&J MedTech's direct enterprise field sales force, targeting tertiary and quaternary hospitals performing interventional pulmonology and thoracic surgery procedures, with clinical evidence (including the BENEFIT and TARGET trials) and physician education as the primary demand-generation channels. The platform has received regulatory clearance in the United States and China, and was previously supported by more than $733 million in pre-acquisition equity funding across multiple rounds from investors including Lux Capital, Mithril Capital, Coatue, Partner Fund Management, and Viking Global Investors. The company has also been an active participant in IP litigation, including a Federal Circuit ruling reviving its challenge against Intuitive Surgical's robotic surgery patent.

Name

Auris Health

Legal name

Auris Health Inc.

Website

https://aurishealth.com

Company type

Private

Founded year

2007

Operating status

Acquired

Headcount range

101–250 employees

Short description

Auris Health, a Johnson & Johnson MedTech subsidiary, develops the MONARCH robotic-assisted bronchoscopy platform with AI-powered navigation for peripheral lung nodule biopsy, serving tertiary hospitals and interventional pulmonologists in the United States and China.

Ownership category

akta.pro rank

Product category

Robotic-Assisted Bronchoscopy Systems

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Bronchoscopy & Interventional Pulmonology (HLAKANAJ), Healthcare & Assistive Robotics (HDAAAIAC)

Keywords

• Robotic bronchoscopy systems
• Surgical robotics platforms
• Lung cancer diagnostics
• Minimally invasive biopsy
• Robotic medical devices

Headquarters

HQ city

Redwood City

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Capital Equipment Sales: The MONARCH Platform is sold as a capital medical device to hospitals and healthcare systems. Revenue is generated from the initial sale and installation of the robotic bronchoscopy system, representing a high-value one-time capital transaction typical of surgical robotics platforms.
2. Procedure-Based Consumables & Accessories: Recurring revenue from single-use accessories and consumables used in each MONARCH-guided bronchoscopy procedure, including biopsy needles and other interventional tools. Generates recurring per-procedure revenue tied to procedure volume.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Auris Health develops and sells the MONARCH Platform, the first flexible, robotically assisted bronchoscopy system that enables physicians to access, visualize, and biopsy suspicious peripheral lung nodules. The enhanced MONARCH QUEST variant adds more powerful AI-powered navigation algorithms and integration with GE HealthCare OEC 3D and Siemens Cios Spin intraoperative imaging systems for tool-in-lesion confirmation. The system is sold as capital equipment to hospitals and healthcare systems, with recurring revenue from per-procedure consumables.

Product overview

Auris Health, now part of Johnson & Johnson MedTech, offers the MONARCH Platform—a robotic-assisted bronchoscopy system for minimally invasive lung nodule biopsy. The platform consists of the core MONARCH Platform and its enhanced variant MONARCH QUEST, which features advanced AI-powered navigation algorithms and integrates with major medical imaging systems (GE Health Care OEC 3D, Siemens Cios Spin). The technology enables physicians to access and visualize airways, reach peripheral lung lesions, and perform biopsies with continuous real-time visualization.

Differentiator

Problem solved

Functional benefit

Brands

• MONARCH Platform: The first flexible, robotically assisted platform for bronchoscopy, providing access to and visualization of airways to enable healthcare providers to biopsy suspicious lung nodules. Now marketed under Johnson & Johnson MedTech.

Products and services

• MONARCH Platform The MONARCH Platform is the first FDA-cleared flexible, robotically assisted bronchoscopy system. It provides access to and visualization of patient airways to enable healthcare providers to biopsy suspicious lung nodules. The system features AI-powered navigation algorithms, continuous intraoperative visualization via an integrated camera, and independently articulating telescoping scope and sheath that can reach all 18 lung segments to access small peripheral lesions with median lesion size of 18.5 mm. It is sold as capital equipment to tertiary and quaternary hospitals and healthcare systems through J&J MedTech's direct enterprise sales organization.
• MONARCH QUEST MONARCH QUEST is the enhanced version of the MONARCH Platform, featuring more powerful AI-powered algorithms for navigation and image processing, with integration capabilities for GE HealthCare OEC 3D and Siemens Cios Spin intraoperative imaging systems. The imaging integration offers an easy-to-use workflow designed to improve targeting accuracy and tool-in-lesion confirmation during biopsy procedures. The advanced AI algorithm generates an airway map that extends further into the periphery of the lungs, improving access to hard-to-reach peripheral lung nodules for interventional pulmonologists and thoracic surgeons.

Quantifiable outcome

• 48% of lung nodules are located in the peripheral third of the lung, requiring reach beyond conventional bronchoscopy capabilities
• +2 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• GE HealthCarecoreTechnology or Integration · 1 May 2025GE HealthCare's OEC 3D imaging system is integrated with the MONARCH Platform for robotic-assisted bronchoscopy. The imaging integration offers an easy-to-use workflow designed to improve targeting accuracy and enable tool-in-lesion confirmation during procedures, providing 3D intraoperative imaging guidance within the MONARCH bronchoscopy workflow.
• Siemens HealthineerscoreTechnology or Integration · 1 May 2025Siemens Healthineers' Cios Spin intraoperative C-arm imaging system is integrated with the MONARCH Platform for robotic-assisted bronchoscopy. This integration enables 3D imaging and tool-in-lesion confirmation to improve targeting accuracy during biopsy procedures, complementing the AI-powered navigation capabilities of the MONARCH system.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Others

• Siemens Healthineers: Siemens Healthineers is the manufacturer of the Cios Spin intraoperative imaging system integrated with MONARCH; comparable as a technology integration partner providing intraoperative 3D imaging within the robotic bronchoscopy workflow.
• GE HealthCare: GE HealthCare manufactures the OEC 3D imaging system integrated with MONARCH; comparable as a technology integration partner providing intraoperative 3D imaging for the robotic bronchoscopy procedure workflow.

Emerging players

• Vicarious Surgical: Vicarious Surgical is an emerging surgical robotics company developing a virtual-reality-enabled robotic platform; comparable as a peer surgical robotics innovator competing for capital and hospital mindshare in robotic-assisted procedures.
• Noah Medical: Noah Medical develops the Galaxy System, a robotic bronchoscopy platform targeting the same peripheral lung nodule biopsy market as MONARCH, representing an emerging direct competitor with focused single-product specialization.
• Asensus Surgical: Asensus Surgical (formerly TransEnterix) develops the Senhance surgical system, an emerging robotic-assisted surgery platform with comparable capital medical device economics and hospital sales motion.

Broad incumbents

• Johnson & Johnson: J&J is Auris Health's parent company and operates the broader MedTech portfolio including MONARCH; it is comparable as the owner and commercialization vehicle for the MONARCH Platform with global MedTech sales reach.
• Stryker: Stryker operates the Mako robotic surgery platform broadly across orthopedics and is expanding robotic applications; as a diversified surgical robotics incumbent, it represents a comparable capital medical device robotics business model.
• Medtronic: Medtronic is a broad MedTech incumbent with endoscopy and bronchoscopy products (including prior robotic-assisted platforms) and significant respiratory diagnostics presence, competing in adjacent interventional pulmonology procedure categories.

Direct peers

• Intuitive Surgical: Intuitive Surgical is the dominant surgical robotics company and a direct competitor in robotic bronchoscopy with its Ion platform, targeting the same peripheral lung nodule biopsy use case with a comparable robotic catheter system.
• Pulmonx: Pulmonx develops endoscopic lung diagnostic and therapeutic devices (Zephyr valves) for interventional pulmonology; comparable as a peer operating in the same physician specialty and bronchoscopy suite workflow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MonarchRobot
• LinkedInlinkedin.com/company/aurishealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds8 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Auris Health